SCHEMBL10345954

SCHEMBL10345954

O=C1CC2(C(=O)N1)c1cc(Cl)ccc1-c1ncccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 4/20 0.55
▸ GSK3A P49840 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ AKR1A1 P14550 2/20 0.39
▸ MEN1 O00255 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ ADRB2 P07550 1/20 0.37
▸ CHRM2 P08172 1/20 0.37
▸ CHRM4 P08173 1/20 0.37
▸ ABCB1 P08183 1/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ CHRM5 P08912 1/20 0.37
▸ ADRA2A P08913 1/20 0.37
▸ CHRM1 P11229 1/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ ADRA2B P18089 1/20 0.37
▸ ADRA2C P18825 1/20 0.37
▸ CHRM3 P20309 1/20 0.37
▸ DRD1 P21728 1/20 0.37
▸ TBXA2R P21731 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10345515 0.85 AKR1B1 (0.55) AKR1B1GSK3AGSK3BAKR1A1CDK5
SCHEMBL9672258 0.84 PDK2 (0.44) MEN1KMT2APDK2
SCHEMBL9751299 0.81 AKR1B1 (0.39) AKR1B1GSK3AGSK3BKMT2ACCNB2
SCHEMBL10930896 0.80 AKR1B1 (0.56) AKR1B1AKR1A1KMT2ACYP11B2CYP11B1
SCHEMBL10907091 0.74 AKR1B1 (0.68) AKR1B1AKR1A1MEN1LMNAADRB2
SCHEMBL9672186 0.73 AKR1B1 (0.56) AKR1B1GSK3BAKR1A1CCNB2CDK1
SCHEMBL8804611 0.71 AKR1B1 (1.00) AKR1B1AKR1A1
SCHEMBL2483457 0.70 AKR1B1 (0.56) AKR1B1MEN1HTR1AHTR2AHTR6
SCHEMBL22609096 0.70 PDK2 (0.44) AKR1B1AKR1A1MEN1LMNAADRB2
SCHEMBL29395626 0.70 PDK2 (0.44) AKR1B1AKR1A1MEN1LMNAADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4609663-A Aldose reductase inhibitors useful in glaucoma therapy ALCON LABORATORIES, INC. (US) 1986-09-02 — — US claimed
EP-0258476-B1 ALDOSE REDUCTASE INHIBITORS USEFUL IN GLAUCOMA THERAPY ALCON LABORATORIES, INC. (US) 1990-04-25 — — EP disclosed
US-4609663-A Aldose reductase inhibitors useful in glaucoma therapy ALCON LABORATORIES, INC. (US) 1986-09-02 — — US disclosed
Send feedback